A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

December 29, 2016

Type of Cancer

Breast Oncology

Site

Hackensack

Sponsor

NRG

Protocol Number

NRG Oncology BR003

To Learn More Call

201-510-0910